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ABSTRACT 
 
Background & Aims: Interval cancers occur more frequently in the right colon. One reason 
could be that right-sided adenomas are frequently missed in colonoscopy examinations. We 
reanalyzed data from tandem colonoscopies to assess adenoma miss rates in relation to 
location and other factors. 
 
Methods: We pooled data from 8 randomized tandem trials, comprising 2218 patients who 
underwent diagnostic or screening colonoscopies (adenomas detected in 49.8% of subjects). 
We performed a mixed effects logistic regression with patients as cluster effects with 
different independent parameters. Factors analyzed included location (left vs right, splenic 
flexure as cut-off), adenoma size, form, and histologic features. Analyses were controlled for 
potential confounding factors such as patient sex and age, colonoscopy indication, and 
bowel cleanliness. 
 
Results: Right-side location was not an independent risk factor for missed adenomas (odds 
ratio [OR] compared with the left side, 0.94; 95% CI, 0.75–1.17). However, compared with 
adenomas ≤5 mm, the OR for missing adenomas 6–9 mm was 0.62 (95% CI, 0.44–0.87) and 
the OR for missing adenomas ≥10 mm was 0.51 (95% CI, 0.33–0.77). Compared with 
pedunculated adenomas, sessile (OR, 1.82; 95% CI, 1.16–2.85) and flat adenomas (OR, 2.47; 
95% CI, 1.49–4.10) were more likely to be missed. Histologic features were not significant 
risk factors for missed adenomas (OR for adenomas with high-grade intraepithelial 
neoplasia, 0.68; 95% CI, 0.34–1.37 and OR for sessile serrated adenomas, 0.87; 95% CI, 0.47–
1.64 compared with low-grade adenomas). Men had a higher number of adenomas per 
colonoscopy (1.27; 95% CI, 1.21–1.33) than women (0.86; 95% CI, 0.80–0.93). Men were less 
likely to have missed adenomas than women (OR for missed adenomas in men, 0.73; 95% CI, 
0.57–0.94). 
 
Conclusions: In an analysis of data from 8 randomized trials, we found that right-side 
location of an adenoma does not increase its odds for being missed during colonoscopy, but 
adenoma size and histologic features do increase risk. Further studies are needed to 
determine why adenomas are more frequently missed during colonoscopies in women than 
men.  
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Right-Sided Location and Miss Rates for Colorectal Adenomas -
Reanalysis of Tandem Colonoscopy Studies 
Risk factors for missing adenomas
• NOT right sided location (odds ratio, 0.94 for right vs left)
• NOT histology (high grade intraepithelial neoplasia, 
serrated adenoma)
• Adenoma size:
Odds ratio, 1.61 for diminutive (≤ 5mm) vs small (6-9 mm)
Odds ratio, 1.96 for diminutive (≤ 5mm) vs large (≥10mm)
• Adenoma form: 
Odds ratio, 2.47 for flat vs pedunculated
• Female sex 
Odds ratio, 1.37 for women vs men
1st exam 2nd exam
Multivariate Analysis
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Introduction 
The advantage of colonoscopy in reducing colorectal cancer (CRC) incidence and outcome is 
to find early cancer but also detect and remove adenomas as precursor lesions. However, 
the protective effect of colonoscopy achieves much less than a 100% CRC reduction
1-3
, and 
various factors may be held responsible
4-6
:  These may be either a different lesion type and 
biology or a miss rate of specific lesions by colonoscopy. Both can lead to so-called interval 
cancers, defined as colorectal adenocarcinomas that are diagnosed between the time of the 
screening colonoscopy, and the scheduled time of surveillance colonoscopy
7
. Histologic 
analyses of such interval cancers have suggested that features related to the serrated 
pathway are more frequently found
8-10
, and it could be that serrated precursor lesions such 
as sessile serrated adenomas/polyps (SSP) which are usually flat, may also be more 
frequently missed. In addition, incomplete polyp resection, especially in larger
11
, but also in 
smaller lesions
12
 may a third factor. So, finally, lesion biology, miss rate and incomplete 
resection may come together to explain interval cancers. 
In addition it has been repeatedly shown in previous publications using large databases, that 
interval cancers occur more frequently in the right colon 6, 13-17. Again, the same factors as 
mentioned above could account for the higher rate of right-sided interval cancers, either a 
different aggressiveness of (precursor) lesions or a higher miss rate on the right colonic side 
by colonoscopy. Concerning the first factor, we have recently shown from an analysis of the 
large German screening colonoscopy database, that risk adenomas (using the surrogate 
parameter of high-grade intraepithelial neoplasia) as well as flat adenomas (as opposed to 
non-flat lesions) are not more frequent in the right colon
18
, suggesting that lesion “biology” 
may not different in the right colon.  
The other explanation is that adenomas as precursor lesions are more frequently missed in 
the right colon, due to a certain failure rate to reach the cecum and/or decreased bowel 
cleanliness in the right colon. Published evidence so far is limited and conflicting; a reanalysis 
of a randomized tandem study concluded from 406 patients that right-sided lesions were 
less frequently missed than left sided ones
19
, contradictory to another retrospective study in 
659 patients undergoing two colonoscopies with a somewhat higher miss rate on the right 
side (for multiple polyps)
20
. 
Therefore, the present study is based on the hypothesis, that there is a higher miss rate of 
adenomas in the right colon which could be a possible explanation for the higher rate of 
right-sided interval cancers. To test this hypothesis, we combined and reanalyzed original 
data from eight published randomized tandem trials
21-28
 which in their original publication 
examined various endoscopic techniques related to imaging and mechanical means (use of 
caps) to reduce adenoma miss rates (AMR). Adenomas found in the second of the tandem 
colonoscopies serve as gold standard for missed lesions; responsible factors are analyzed 
further in a multivariate analysis. 
 
Methods 
Authors of published randomized tandem colonoscopy studies were contacted after a 
careful PubMed search with the terms “colonoscopy” AND “tandem” (alternatively “back to 
back”, “same day”) OR “miss/missed/miss rate/additional adenoma” (alternatively) AND 
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“randomized”. The search was done in early 2015 covering the period after introduction of 
HD endoscopes in 2006, i.e. related to original papers published between 2007 and 2015. 
Only full text English language publications (randomized tandem trials) with 100 cases or 
more covering diagnostic or screening colonoscopy were to be included. Studies on special 
conditions (inflammatory bowel disease, polyposis syndromes, postoperative follow-ups) 
were excluded. Of 26 such studies shown as full text publication and in English language, 
which did not include special conditions such as IBD or Lynch syndrome, 15 had more than 
100 patients and were real tandem studies (two full colonoscopies performed, and not 
limited to the right or left colon). Authors were contacted by mail several times, and seven 
groups finally agreed to send their data from a total of eight studies, with data transferred to 
excel files
21-27
. An own tandem study which finished patient recruitment in 2014 but was 
published later, was also included
28
. These were 4 single-center
21-23, 26
 and 4 multicenter 
studies
24, 25, 27, 28
.  In addition, original data from another study were also received but 
tandem examinations were done only in the right colon
29
. Before final analysis, several 
feedback rounds with the authors were necessary to streamline the data and combine them 
into one database; these concerned different categorizations of adenoma size, forms and 
locations as well as histology definitions (e.g. for advanced adenoma). All authors had had 
access to the study data and had reviewed and approved the final manuscript. 
Study performance characteristics: The methodological details of the included studies are 
shown in Table 1. The following categories were used for this combined analysis: 
1. Indication for colonoscopy: screening, diagnostic, surveillance 
2. Bowel cleanliness: (excellent, good, fair, poor) 
3. Patient age and sex 
4. Polyp size: mm categories (1-5mm, 6-9mm, ≥10mm) 
5. Polyp form: flat, sessile, pedunculated 
6. Polyp location: left=distal (rectum, sigmoid and descending colon) versus right 
(transverse colon including flexures, if analysed separately, and ascending colon, 
cecum) 
7. Histology: see below 
 
Histopathology definitions and inclusion: Only lesions with histologic proof were included; 
thus, lesions in the database excluded from analysis which did not have histopathologic 
proof by polypectomy or at least biopsy. Hyperplastic polyps, adenomas with low- and high-
grade intraepithelial neoplasia as well as (submucosally) invasive cancers were defined in the 
studies according to international standards
30
; central histopathology reading of all cases in 
one given study (if multicentric) was not available in any of the 4 multicentric studies. In only 
6 of the 8 studies, sessile serrated adenomas/polyps (SSA/P) were defined as separate 
entity. Therefore, these 6 papers underwent the same analysis as described above for all 8 
studies but with the additional parameter SSA/P as a risk factor for missing polyps. 
Outcomes and definitions: Primary outcome was a missed adenoma. Missed adenomas were 
defined as those, not detected the first pass but by the second pass of the tandem 
examination which served as gold standard. AMR was calculated both on an adenoma basis 
(all missed adenomas/all patients) as well as on a patient basis (all patients with at least one 
adenoma missed). Only patients with polyps with adenomatous histology were considered. 
The primary predictorof interest was adenoma location. Secondary predictors of interest 
were other factors of possible influence on missed adenoma such as patient factors (sex, 
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age), indication for colonoscopy, colonoscopy factors (bowel cleanliness). These were 
analyzed with a multivariate analysis described in the following. 
Statistics: Only patients with adenomas in one of the two passes were included in analysis 
who had a full dataset with regards to histology, size, form and location. Carcinomas (sm and 
more), hyperplastic polyps and other lesions were excluded (see Figure 1). Sample 
characteristics are given as absolute and relative frequencies or mean +/- standard 
deviation, whichever is appropriate.  
The prevalence of “adenomas not detected during the first pass” was analyzed using a mixed 
effects logistic regression because of every patient could have multiple detected adenomas a 
random intercept for the cluster patient was modeled. A random effect for the studies 
cannot be included because the effects of the combination of instruments and study cannot 
be separated, since one study includes one combination and some combinations are 
represented by one study only. 
The combination of instruments, size, histology, form, location as well as all interactions of 
location with the other adenoma characteristics were considered as possible factors of 
influence and simultaneously included in the model (multivariate analysis). Moreover, the 
potential confounders gender, age, bowel preparation, total number of polyps within patient 
and indication were added to the model. In the case of an insignificant interaction term only 
the main effects were included, this decision was met by using the likelihood ratio test for 
model comparison. No further model selection methods were performed. Results are 
visualized by forest plots showing adjusted odds ratios (ORs) with corresponding 95%-
Confidence intervals (CI). 
A two-tailed p < 0.05 was considered to be statistically significant. Nominal p-values are 
reported without correction for multiplicity. Statistical analyses were computed using Stata 
14.1 (STATA Corporation, College Station, Texas, USA). 
 
 
Results 
 
Overview of study patients and lesions 
Of a total of 2218 patients included in the eight studies into this analysis, with one examiner 
performing the tandem examination in 6/8 studies (and two examiners in the remaining 
two). 1125 cases were excluded due to various reasons, mainly for absence of any polyps 
and cases with hyperplastic polyps only. Also, 7 cancer cases (i.e. tumors with submucosa 
invasion and beyond) had been excluded. Thus, 1093 patients with a total of 2401 adenomas 
were the basis of this analysis (see flow sheet in Figure 1). Patient and procedural data are 
shown in Table 2, overall results for adenomas found during both colonoscopy passes in 
Table 3. There was no correlation between adenoma shape and location (p=0.482), so 
certain adenoma shapes were not more frequent in certain locations. Figure 2 shows the 
number of adenomas found during the first and second pass separately related to the 
number of patients. 
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Miss rates and factors 
Results of the multivariate analysis with regards to patient- and adenoma-related miss rate 
factors are shown in Table 4 and Figure 3. All investigated interaction terms of adenoma 
characteristics with location (location by size, location by histology, location by form) 
showed no significant effects. Therefore in the final model only the main effects (location, 
size, histology and form) were included. Right-sided location was not found to be a risk 
factor for missing adenomas in these studies. To see whether there is a difference by 
histology or size that is still site-specific we additionally performed our described model by 
adding the interaction term of location and size and location and morphology and location 
and histology. There is no significant effect of the adenoma location for any adenoma 
characteristics (morphology by location p=0.426 / size by location p=0.775 / histology by 
location p=0.210).) Therefore a global side-independent effects of the patient characteristics 
can be assumed.  
As expected, larger polyp size was independently associated with lower miss rates. Flat (OR 
2.47; 95%-CI: 1.49,4.10) and sessile adenomas (OR 1.82; 95%-CI: 1.16,2.85) were more 
frequently missed than pedunculated polyps, and there was also a significant difference 
between flat and sessile adenomas (OR 1.36 95%-CI: 1.02,1.80; p=0.036). Other factors such 
as adenoma histology and patient age were not significantly associated with the probability 
of being not detected in first exam.   
Furthermore, another risk factor for AMR was female gender (OR 1.37; 95%-CI: 1.06,1.75, 
p=0.011; for men OR 0.73; 95%-CI: 0.57,0.94, p=0.011). As for adenoma occurrence in both 
sexes, the adenoma rate per colonoscopy (APC) was higher in men: APC was 1.27  (95%-CI: 
1.21;1.33) for males (1678 adenomas/1322 men) and 0.86 (95%-CI: 0.80;0.93) for females 
(754 adenomas/872 women). 
Bowel preparation was not a risk factor in this analysis with the exception of borderline 
significance for the lowest grade/poor preparation (OR 1.92, 95%-CI: 1.00;3.68, p=0.048). If 
the grades were grouped differently, namely excellent/good and fair/poor together (as done 
in some of the papers included), results were not significant either (OR 1.25, 95%-CI: 
0.90,1.74; p=0.182). 
As for histologic differentiation, results for SSA/P could only be analyzed from 6/8 studies 
(2112/2395 adenomas) in which these lesions were separately categorized. The OR from 
these 6 studies for sessile serrated histology was 0.88 (95%-CI: 0.45;1.70) and not significant 
(p=0.695), and this does not differ to the complete sample. Detailed results of these 6 
studies are shown in Table 1 online and were similar for the other parameters analyzed as 
compared to the combined analysis of data from all 8 studies. 
The influence of colonoscope characteristics on AMR which were the main topic of the 
respective studies, were included in the multivariate analysis but this aspect is shown 
separately in Table 2 online.  As detailed in the individual studies, the method tested was 
mostly associated with a lower miss rate when performed first as compared to its use during 
the 2
nd
 pass.  Furthermore we investigated a second starting model with above describe 
interaction terms as well all interaction terms between instrument and adenoma 
characteristics (instrument by location, instrument by histology, instrument by size and 
instrument by form). After a model selection with likelihood ratio test we found no 
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significant interaction term, so the resulting model is always the model with the main effects 
only. 
 
 
Discussion 
Interval colorectal cancer (i-CRC) is the “negative” outcome parameter on the effectiveness 
of (screening) colonoscopy. Post-colonoscopy follow-up studies reported that even after a 
clear colon (following polypectomy of all detected lesions) the reduction of CRC incidence 
was much less than 100%
13, 17
. Thus, i-CRC can be considered as failure of colonoscopy to 
prevent CRC and has been shown to be associated with right sided location in a recent meta 
analysis
16
. Also, recently, definitions and possible causes were summarized in a consensus 
statement
7
. As in previous analyses, assumptions are that about 50% of i-CRC are due to 
missed lesions, and around 25% each due to either incomplete resection or de novo 
development
4, 6
.  
The striking side-difference between the left and right colon in the occurrence of i-CRC 
which was shown in post-colonoscopy follow-up studies
13, 14, 17
 as well as one meta analysis
16
  
is one of several unsolved issues. Another recent review on i-CRC definitions summarized 
screening and combined (screening and diagnostic colonoscopy) studies in different tables
31
: 
In this analysis, there was only a significant difference in the combined studies, while studies 
with screening colonoscopies only (much lower in total case number) had equal numbers of 
right- and left sided i-CRCs. The meaning of this possible difference between study types is 
unclear. 
If this difference between right- and left sided interval cancers holds true for colonoscopy 
and also screening colonoscopy, it is not easy to explain. It could be due to a different 
biologic behavior of right-sided lesions or a higher miss rate or a combination of both. We 
recently showed from a very large database analysis of more than 5 million screening 
colonoscopies in the German National Screening database, that right-sided lesions did not 
have a higher rate of risk parameters such as high-grade intraepithelial neoplasia
18
. In the 
literature, results of  “biology” of proximal versus distal adenomatous lesions provides only 
indirect evidence from analysis of primary lesions as well of post-resection recurrences 
which is somewhat controversial with regards to proximal lesions
11, 32-35
.  
Thus, it is likely that not biology, miss rate of lesions might be higher in the right colon to 
account for the higher rate of right-sided i-CRC. This may be due to a variety of factors such 
as failure to reach the cecum, reduced bowel cleanliness in the right colon, higher 
prevalence of right-sided flat lesions such as flat adenomas or sessile serrated 
adenomas/polyps (SSA/P). However, our reanalysis of original data from 8 studies did not 
confirm a higher proximal adenoma miss rate in a multivariate analysis. This confirmed 
results of a previous much smaller single-center study on 406 cases where miss rate was 
even higher in the left colon
19
. Our analysis is different from other meta analyses since we 
did not use published data from the respective papers as in a classical meta analysis, but 
combined original data from the randomized trials. Although we were dependent on 
authors, contributing their data, this type of analysis may be more precise.  In fact, it took 
quite some efforts and enquiries with feedback from the authors to pool different size and 
histology categories as well as location. For example, the cut-off between left and right colon 
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was quite inhomogeneous in the studies included in our trials, ranging from either two 
segments with the splenic flexure as cut-off to 3, 5 or 6 segments including the flexures as 
separate location
21-28
. These details are not obvious  
Another possible limitation of our analysis is which studies were selected. Our selection was 
firstly based on our literature search included only fully published randomized trials in 
English language journals, true tandem studies (two full colonoscopies), studies with at least 
100 cases, and those published after the introduction of HD colonoscopy after 2006. 
Secondly, of the 15 suitable studies we found between 2008 and 2015 under these selection 
criteria, we could obtain original data from only seven papers; as an 8
th
 study, we added 
data from a tandem study of our own group finished by that time. This selection may be a 
limitation of the existing study, but we were dependent on the voluntary cooperation of 
other groups. In addition, no study has been done in a pure screening collective, so that 
primary adenoma detection rates were rather high, namely mostly between 35 and 50% (see 
Table 1). Furthermore, we only received data from studies testing a new technique in the 
tandem approach, which may possibly lead to examiner bias towards the new method, a 
bias which cannot be excluded. The only tandem study with the same technique used in 
both arms could not provide us with original data; as it seems from the paper, there was a 
higher miss rate only in the left colon when compared to the rectum as reference (OR 2.9), 
while transverse and right colon did not have increased miss rates, again pointing towards 
an increased miss rate in the left rather than the right colon
36
. 
A further limitation of the present analysis is that we ended inclusion of studies after 2015 
since detailed analysis, author feedback and data homogenization took some time. Another 
literature search done since 2015 until present revealed 55 citations, and after exclusion of 
reviews, meta-analyses, secondary studies summarizing previous papers, tandem studies on 
the entire colon (instead of only right sided tandem) and data available on location, 7 studies 
remain
37-43
, which in an additional paper-based meta analysis done by one of us (GGC) did 
not a higher miss rate in the right colon, rather a trend of a higher miss rate on the left side 
(see Figure 1 online). 
What can we conclude from our results? It has to said that, even if, under study conditions 
of a tandem colonoscopy, proximal location could not be identified as a risk factor, there 
may be other circumstances under different study conditions and/or in real life which 
nevertheless may lead to a higher proximal miss rate.  A reanalysis of three polyp prevention 
trials found a higher rate of proximal adenomas after a (seemingly) clean colon, whereby 
recurrent and missed cancers may be difficult to differentiate
44
. Furthermore, the fact that 
the miss rate is monitored such as in a tandem study, may per se lead to a higher 
attentiveness of participating colonoscopists, so that the first pass may reveal higher primary 
ADR (and hence, lower AMR) than in daily life. Secondly, in supervised national screening 
programmes (self-reported) cecal intubation rates are usually over 90%, such as shown in 
Germany
45
, Austria
46
, Norway
47
, The Netherlands and UK
48
, with somewhat lower rates for 
France
49
, but in countries and areas with less rigorous quality and documentation 
programmes, cecal intubation rates may be substantially lower
50-52
.  Furthermore, cecal 
rates always depend on self-reporting, without an easy independent gold standard. 
However, documentation quality of cecal reach may be limited
53, 54
, the independent 
assessment of cecal photographs leads to variable results
55-57
, and comparisons with 
external imaging such as scope guide for cecal reach are not available; however, 
colonoscopic localization of lesions has been repeatedly shown to be inaccurate in nearly 
20% of cases when compared to magnetic imaging (scope guide) and other controls such as 
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CT or even surgery
58, 59
; whether this could be extrapolated to a limited accuracy to define 
full cecal intubation, is likely, but finally unknown. In any case, we need more long-term 
follow-up studies from the various screening programmes on either primary screening 
colonoscopy or stool-based screening programmes to find out whether there is a clear 
predominance of right sided missed cancers.  
The same may be true for bowel cleanliness; only in the category “poor” was there was a 
significantly higher miss rates, which confirms previous experience by our group
60
 and by 
others. For most studies on ADR and AMR as well as for large colonoscopy databases, the 
assessment bowel cleanliness again rests on self-reporting. However, there is evidence that 
bowel cleanliness is rated better by colonoscopists than by external validation (video 
assessment) by independent experts
61, 62
.  In addition, different scores and ratings have been 
used for all these studies and databases, so that comparability is limited, as can be seen by 
very different cleanliness scores, e.g. in the Austrian
46
 and British programme reports on 
94% excellent/adequate cleansing rates
48
.  
The assumption of a higher miss rate in right-sided adenomas in real life as compared to 
study conditions of our tandem analysis would also imply that missed lesions (and hence 
interval cancers) would increase in frequency from the mid colon to the cecum since the 
most distal parts the areas with assumed detection failures when the cecum is not reached 
and/or the ascending colon and cecum are the least clean parts. Unfortunately, only few 
studies reveal the precise location of interval cancers, but of 76 such cancers, 47% were 
located in cecum and ascending colon in a German screening study
63
, while in a Polish 
screening study with 42 interval cancers, only 7 were located in these segments
64
. In 
combined studies analyzing screening and diagnostic colonoscopies, the two largest showed 
either 43% of 874 i-CRC with known location in cecum or ascending colon (only 7% in 
transverse colon)
65
, or, as in the larger study, 31% in cecum, 29% in ascending colon 
including hepatic flexure in a total of 4104 i-CRCs
66
. In analogy, our own Exera III study 
including 856 patients, 37% of all missed adenomas were located in the cecum and 
ascending colon, 25% in the transverse colon and 48% in the left colon 
28
.  
A further issue is that serrated adenomas (SSA/P) were not missed more frequently per se in 
our analysis (however flat adenomas showed a higher miss rate than sessile or pedunculated 
ones). It could be that in the two studies, which did not have SSA/P as separate category, 
these lesions were counted among hyperplastic lesions. However, it is unlikely that histologic 
subdifferentiation in these two papers would have changed the results substantially, since 
results in the remaining 6 papers were clear with an OR of 0.87 and none of the other 
parameters analyzed was much different between the analysis of all 8 studies (see Table 4) 
and the 6 studies with SSA/P analyzed separately (see Table 1 online). In general, both 
endoscopic and histologic diagnosis of SSA/P are subject to substantial interobserver 
variability, at least in most studies
67, 68
, which makes interpretation of most study results 
more difficult than for conventional adenomas. 
 In conclusion, in a careful tandem colonoscopy under study conditions, adenomas are not 
more frequently missed in the right colon. We do not know whether miss rate might be 
substantially higher in the right colon in real life colonoscopy or whether other factors 
account for the higher rate of interval cancers in the right colon. In all likelihood, it is not a 
higher miss rate for sessile serrated adenomas either, as we also could show. These results 
could also be interpreted in a way, that applying a higher scrutiny in the right colon than 
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done in daily practice - as might be the case in tandem studies – could help to solve the 
problem of a higher rate of right-sided interval cancers and overall effects of colonoscopy. 
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FIGURE LEGENDS 
 
 
Figure 1: Flow sheet of patient and lesion inclusion in our analysis 
 
 
Figure 2: Combined patient numbers with adenomas found during first and second pass 
 
 
Figure 3: Risk factors for missing an adenoma in the multivariate analysis (see text) 
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Table 1: Characteristics of the included studies in order of paper publication year (methodology as described in the resp.paper) 
< 
     STUDY 1
21
  STUDY 2
22
 STUDY 3
23
 STUDY 4 
24
 STUDY 5
26
 STUDY 6
25
 STUDY 7
27
 STUDY 8
28
   
 
GENERAL 
No of patients   276  100  96  349  360  98  116  856 
Study topic (new method)  NBI  Cap  HDTV  Third Eye  NBI  FUSE  Endorings 2 generational 
Study period (months)   13  35  23  12  12  14  12  22 
 
METHODOLOGY 
Indications (%)   SC,SV,D  SC,SV   SC,SV  SC,SV,D  SC,SV,D  SC,SV,D  SC,SV,D  SC; D 
No of centers in study   1  1  1  9  1  6  3  6 
No of examiners in study  6  2  8  15  8  15  6  several 
Experience (colonoscopy no)  n.r.  n.r.  5000  long experience 500-2000
+
 n.r.  n.r.  500  
One/two examiners per pat.  1  1  2  1  1  1  1  2 
Bowel cleanliness score BBPS  3 grades  5 grades  Ottawa score 4 grades  Ottawa score BBPS  BBPS 
Sedation used   M/F, P  P  M + F/MP n.r.  M, F or PE M, F, P  M/F, P  M,P 
Examination times (min)   
  Overall times   +  +  +  n.r.  n.r.  14.5 vs 12.2
§
 22 vs 18.5
§ 
diff
++++
 
  Withdrawal    +  +  +  n.r.  9.9 vs 10.4 6.2 vs 5.62
§
 7.4 vs 7.2  diff
++++
 
Histologic criteria*   all  all  all + VC** all +VC  all  diff. grouping
++
 all  all 
SSA separate category* yes  no  yes  yes  yes  ?  yes  yes 
Excluded lesions w/o histology  no   no  no  no  no  no  no  no 
Polyp localization documented  prox/distal (SF) 6 segments 8 segments 8 segments 3 segments prox/distal (SF) prox/distal (SF) 6 segments 
Polyp size documented   mm  mm  mm  mm  mm  3 categories
+++ 
mm  mm 
Polyp form documented  ped/sess/flat ped/sess/flat no  ped/sess/flat ped/sess/flat ped/sess/flat ped/sess/flat Paris 
Case number calculation  15% vs 30% AMR 15% vs 30% AMR 20% vs 31% n.r.  ADR 50% vs 35% AMR 15% vs 35% AMR 10% vs 35% 10% vs 20% 
 
RESULTS   
Overall ADR after 2 passes  49%  49%  44%  46%  61%  63%  57%  52% 
a-AMR new vs control   15% vs 12% 12.6% vs 12.1% 27% vs 49%
§
 21% vs 29%
§
 22% vs 21% 23% vs 62%
§ 
12% vs 47%
§
 17% vs 30%
§
 
ADR first pass (new vs control)  50% vs 44% 50% vs 44% 25.5% vs 37% n.r.  48% vs 34%
§
 34% vs 28% 49% vs 29%
§
 44% vs 36.5%§ 
     
 
§ significant (P < 0.05).  Abbreviations: n.r. not reported. Indication: SC screening, SV surveillance, D diagnostic. BBPS Boston Bowel Preparation Score. Sedation: M midazolam, F fentanyl, P propofol, MP meperidine, PE 
pethidine. ADR adenoma detection rate (patients with at least one adenoma/all patients), a-AMR adenoma miss rate on adenoma basis. SF splenic flexure as cut-off between proximal and distal 
*  all = hyperplastic polyps, adenoma with low/high-grade intraepithelial neoplasia, submucosally invasive cancer (if found) as categories in all papers. VC = Villous components mentioned (i.e. tubular/tubulovillous/villous) 
** in this paper tubulovillous was combined with HGIN adenoma in one group  
+
500 for fellows and 2000 for experts 
++
 3 groups: LGIN, HGIN plus villous components, hyperplastic/normal tissue, no SSA menitoned.  
+++
 1-5 mm, 6-9mm, ≥ 100 mm. 
++++
 net withdrawal and overall times significantly different between groups, but in different directions (see paper for details)
28
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Table 2: Combined study data (mean; range) on the 1093 study patients with colonoscopy performance 
characteristics 
Patient data      mean   range  
 
Sex   Female     373 (34,1%)   
   Male    720 (65,9%) 
 
Age       62.2    ±9.9 
 
Colonoscopy data 
 
Indication  Screening   335 (30,6%)  
   Surveillance   380 (34,8%) 
   Diagnostic   373 (34,1%) 
   Missing/unknown/other 5     (0,5%) 
 
Bowel cleanliness Excellent   369 (33,8%) 
   Good    547 (50,0%) 
   Fair    140 (12,8%) 
   Poor    37 (3,4%) 
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Table 3: Combined study data (mean; range) on detected and missed polyps/adenomas in the study 
patients during both passes of tandem colonoscopy; for patient numbers and inclusion/exclusion see 
Figure 1, for additional adenomas found during the second pass, see Figure 2** 
 
          
Patient basis (N = 2194 patients.*) 
 
Adenoma detection rate  
  ADR (% of patient with at least one adenoma)   
  Overall (both passes)    49.8% (1093 adenomas/2194 patients)   
  1
st
 pass      n = 908 with at least one adenoma 
  2
nd
 pass      n = 447 with at least one (more) adenoma**  
 Mean no of adenomas/adenoma carrier (overall) 2.19 (2401/1093)  
 
 
 Subgroup detection rate (N = 2194)  
 (% of patients with at least one such adenoma-multiple responses per patient are possible) 
• LGIN adenoma     47,6% (1045/2194)   
• HGIN adenoma     2.8% (62/2194)   
• SSA/P      2.9% (64/1998***) 
• Right-sided adenoma    50.0% (1097/2194) 
• Flat adenoma     26.5% (582/2194) 
 
 
Adenoma features (N = 2401 adenomas) 
 
Adenoma size (mm) 
 1-5 mm       76.6% (N = 1839)  
 6-9 mm       14.8%  (N = 355) 
 ≥ 10 mm      8.6% (N = 207) 
 
Adenoma histology 
 Adenoma, LGIN      92.8% (N = 2229) 
 Adenoma, HGIN     3.2% (N = 77) 
 SSA/P*       4.5%* (N = 95) 
  
Adenoma location  
 Left side      41.2% (N = 989) 
 Right side      58.8% (N = 1412) 
 
Adenoma  morphology 
 Flat       28.7% (N = 690) 
 Sessile       62.1% (N = 1491) 
 Pedunculated      8.9%  (N = 214) 
 Depressed      0.2% (N = 6) 
 
 
Abbreviations: LGIN low grade intraepithelial neoplasia, HGIN high grade intraepithelial neoplasia, SSA/P serrated 
adenomas/polyps, sm submucosal infiltration 
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* overall patient numbers with two completed tandem colonoscopies (see Figure 1); in 32 cases no polyp histology 
was available- subtracting these cases would lead to slightly different figures, e.g. overall ADR 50.55% (1093/2162) 
** see Figure 2 
*** SSA/P are separately analyzed in only 6 papers, therefore total n of adenomas=1998 instead of 2401 
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Table 4: OR of missed lesions in relation to colonic location and other factors; reference values for 
parameters are given in brackets (=ref.). This analysis is based on 1092 patients with 2395 adenomas 
(due to small group size of depressed form, 6 adenomas were excluded from the analysis sample).  
 
Results model  
 
 
Missed at first examination 
 
OR 
 
P-value 
(comparison to 
reference) 
 
 
95%-CI 
 
COLONOSCOPY 
Indication (ref. screening) 
 
 
Pgroup comparison = .499 
Diagnostic 1.13  0.82,1.54 
Surveillance 0.99  0.73,1.35 
missing/unknown/other 0.26  0.03,2.63 
 
PATIENT FACTORS 
Patient sex (ref. female) 
 
Male 0.73
*
 .011 0.57,0.94 
 
Patient age per 1-year-increase 
 
1.00 
 
.667 
 
0.99,1.02 
 
Bowel preparation (ref. excellent) 
 
Pgroup comparison = .151 
Good 1.23  0.94,1.61 
Fair 1.35  0.90,2.02 
Poor  1.92
*
  1.00,3.68 
 
ADENOMA CHARACTERISTICS 
Adenoma localisation (ref. left)  
   
right 0.94 .545 0.75,1.17 
 
Adenoma size (ref. 1 to 5 mm) 
 
Pgroup comparison < .001 
6 to 9 mm 0.62
**
 .005 0.44,0.87 
≥ 10 mm 0.51
**
 .002 0.33,0.77 
 
Adenoma morphology (ref. 
pedunculated) 
 
Pgroup comparison < .001 
Sessile  1.82
**
 .015 1.16,2.85 
Flat    2.47
***
 .000 1.49,4.10 
 
Histology (ref. LGIN adenoma) 
 
pgroup comparison = .532 
HGIN adenoma 0.68  0.34,1.37 
Sessile serrated adenoma 0.87  0.47,1.64 
 
Total number of polyps  
 
0.98 
 
.352 
 
0.93,1.02 
 
Observations 2395   
 
Analysis sample 2395 adenomas in 1092 patients (6 cases of depressed adenomas were excluded because of collinearity) 
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Exponentiated coefficients 
*
 P < .05, 
**
 P < .01, 
***
 P < .001 
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SUPPLEMENTARY MATERIAL ONLINE 
 
Figure 1 online: Meta analysis of randomized tandem studies fulfilling our inclusion criteria (see 
Methods p.3 and 4) and being published from 2015 until now (papers from ref. 38-44); mean age in this 
analysis was 62 years, 61.4% were male.    
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Table 1 online: Results of 6/8 studies in which SSA/P were analyzed separately: OR of missed lesions in 
relation to colonic location and other factors; reference values or parameters are given in brackets (ref.). 
This analysis is based on  990 patients with 2112 adenomas 
 
Results model  
 
Missed at first examination 
 
OR 
 
p-value 
(comparison to 
reference) 
 
 
95%-CI 
 
Indication (ref. screening) 
 
pgroup comparison= 0.863 
Diagnostic 1.14 0.467 0.82,1.54 
Surveillance 1.00 0.992 0.73,1.35 
missing/unknown/other 1.00   
 
Patient sex (ref. female) 
 
Male 0.75
*
 0.040 0.56,0.99 
 
Patient age per 1-year-increase 
 
1.00 
 
0.840 
 
0.99,1.01 
 
Bowel preparation (ref. excellent) 
 
pgroup comparison=0.530 
Good 1.26 0.128 0.93,1.71 
Fair 1.44 0.096 0.94,2.21 
Poor  2.02
*
 0.091 0.98,4.58 
 
Adenoma localisation (ref. left)  
   
right  1.08 0.555 0.84,1.37 
 
Adenoma size (ref. 1 to 5 mm) 
 
pgroup comparison <0.001 
6 to 9 mm 0.63
**
 0.013 0.43,0.91 
≥ 10 mm 0.53
**
 0.007 0.34,0.84 
 
Adenoma form (ref. pedunculated) 
 
pgroup comparison <0.001 
Sessile  1.97
**
 0.007 1.21,3.20 
Flat    2.50
***
 0.001 1.42,4.40 
 
Histology (ref. LGIN adenoma) 
 
pgroup comparison = 0.532 
HGIN adenoma 0.73 0.400 0.35,1.51 
Sessile serrated adenoma 0.88 0.695 0.45,1.70 
 
Total number of polyps  
 
0.97 
 
0.314 
 
0.92,1.03 
 
Observations 2112   
 
Analysis sample 2112 adenomas within 990 cases (see Table 3). Exponentiated coefficients. 
*
 p < 0.05, 
**
 p < 0.01, 
***
 p < 0.001 
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Table 2 online: OR of instrument characteristics for missed adenomas which were part of the 
multivariate analysis but which are not shown in Table 3 (reference is two white light examination for 
both passes, i.e. WSL followed by WL) 
 
 
 
Instrument order (ref. WL->WL) 
 
pgroup comparison<0.001 
 
WL->NBI/FICE     2.79
***
 <0.001 1.83,4.27 
WL->TER/full spectrum   2.17
**
 0.004 1.28,3.67 
WL->EndoRings/Cap   2.35
**
 0.002 1.38,4.01 
NBI/FICE->WL 0.92 0.704 0.60,1.41 
NBI/FICE->NBI/FICE 0.95 0.837 0.55,1.61 
TER/full spectrum->WL 0.68 0.182 0.39,1.20 
EndoRings/Cap->WL 0.73 0.317 0.40,1.35 
 
 
 
 
 
 
 
 
